• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Archives for October 2005

EU Elevates Geographical Indications As Priority For Hong Kong

28/10/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment

Geographical indications (GIs) have become a political issue and a key priority for the European Union in the run-up to the December World Trade Organization ministerial in Hong Kong as GIs today officially became part of the EU’s agriculture package. As the EU proposed further cuts in its agriculture sector as part of the current […]

Filed Under: English, WTO/TRIPS

TRIPS Council Issues Still Alive For WTO Ministerial

28/10/2005 by William New, Intellectual Property Watch Leave a Comment

The World Trade Organization committee handling intellectual property issues finished four days of meetings with minimal progress in real terms, but kept several issues alive for the December WTO ministerial in Hong Kong. The WTO Council on the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) met from 25 to 28 October. Issues still […]

Filed Under: English, WTO/TRIPS

Pandemic Fears Raise Questions About WTO Health Waiver Opt-Out

27/10/2005 by William New, Intellectual Property Watch Leave a Comment

As nations prepare for a possible avian flu pandemic, some observers are raising questions about a seemingly obscure footnote in international trade law under which dozens of governments have agreed not to import cheap generic drugs made for poor countries. The concern is that the provision could make it difficult for those developed countries to […]

Filed Under: English, Health & IP, WTO/TRIPS

Intellectual Property Watch Announces New Associate Editor

27/10/2005 by William New, Intellectual Property Watch Leave a Comment

Intellectual Property Watch is happy to welcome Tove Iren Spissøy Gerhardsen to its ranks as its new Associate Editor. She will be covering a full range of IP policy issues, including the areas of health, trade, and other developments at the international, regional (such as the European Union) and national levels. Tove was most recently […]

Filed Under: Editorials, English

US, Switzerland, Japan Launch New WTO Probe On China’s IP Enforcement

26/10/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment

The United States, Japan and Switzerland have taken bilateral actions through the World Trade Organization to probe China’s intellectual property rights enforcement, despite Chinese objections. The three nations are requesting more transparency based on Article 63.3 of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). During the 25 October TRIPS Council meeting, […]

Filed Under: Enforcement, English, WTO/TRIPS

No Agreement On Public Health At TRIPS Council

25/10/2005 by William New, Intellectual Property Watch Leave a Comment

Officials at the World Trade Organization committee responsible for intellectual property issues on Tuesday could not agree on how to permanently change trade law to permit poor countries in need to import drugs made elsewhere under compulsory license. The WTO Council on the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is under mandate […]

Filed Under: English, Health & IP, WTO/TRIPS

Avian Flu Issues Could Arise At TRIPS Council Meeting

25/10/2005 by William New, Intellectual Property Watch Leave a Comment

Issues surrounding nations’ legal ability to obtain sufficient quantities of patented medicines to protect their people from the spread of avian influenza may be addressed at today’s meeting of the World Trade Organization committee responsible for intellectual property rights matters. The meeting of the WTO Committee on the Agreement on Trade-Related Aspects of Intellectual Property […]

Filed Under: English, WTO/TRIPS

Indian Industry Pushing for Compulsory Licenses for Tamiflu

25/10/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment

While Swiss-based Roche, the rights holder to the most-favoured medicine for avian influenza, is pursuing sub-licenses, India is moving ahead with exploring the option of compulsory licensing. If this goes through, India would be able to export Tamiflu to developing countries and certain developed countries. The Indian Cabinet is considering issuing compulsory licenses to local […]

Filed Under: Venues, Asia/Pacific, English, Health & IP, Patents/Designs/Trade Secrets, Regional Policy, WTO/TRIPS

Official: In WTO Talks, US Pushes Russia To Restrictive TRIPS Standard

24/10/2005 by William New, Intellectual Property Watch Leave a Comment

Russia is negotiating for accession to the World Trade Organization at the same time it is talking with the United States bilaterally about exceeding the terms of the WTO agreement on intellectual property rights, and a senior Russian official said last week that the two have become intertwined. According to Russia’s lead negotiator on WTO […]

Filed Under: English, WTO/TRIPS

Roche Seeks Deals On Bird Flu Drug As Compulsory Licenses Loom

20/10/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch 1 Comment

Roche, the Swiss-based company with rights to a medicine believed to be the most effective in the event of an avian influenza pandemic, has expressed openness to discussing arrangements with companies or governments to produce more of its flu treatment known as Tamiflu. But sceptics argue that the offer, made on 18 October, is too […]

Filed Under: English, Health & IP, Patents/Designs/Trade Secrets, WHO, WTO/TRIPS

  • 1
  • 2
  • 3
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2019 · Global Policy Reporting